Coelho MLN, Saldanha L, Auad H, Castro ME, Fraga R. GLP-1 RECEPTOR AGONISTS AND SGLT-2 INHIBITORS BEYOND GLYCEMIC CONTROL: CARDIOVASCULAR BENEFITS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS. REASE. 2025;11(10):2102-2110. doi:10.51891/rease.v11i10.21484